The global pet hospice services market size was estimated at USD 0.7 billion in 2025 and is projected to reach USD 1.5 billion by 2033, growing at a CAGR of 10.3% from 2026 to 2033. The market is primarily driven by factors such as surging demand for at-home pet hospice services, a rising geriatric and terminally ill pet population, accelerating palliative care uptake, efforts to standardize animal hospice protocols, and growing awareness initiatives normalizing pet hospice conversations.
The global companion animal population is aging, expanding the addressable base for pet hospice services. Improved routine veterinary care, advances in nutrition, and wider access to diagnostics have extended average pet lifespans over the past two decades, producing a structurally larger cohort of geriatric animals requiring sustained end-of-life management. This demographic shift is particularly pronounced among dogs and cats, the two species that account for the dominant share of pet hospice demand, where the incidence of chronic, age-associated terminal conditions has risen in tandem with longer lifespans.
Cancer represents the most clinically significant terminal condition driving hospice referrals. According to a December 2025 publication by PetMD, approximately 25%, i.e., around 1 in 4, of dogs will develop some form of cancer during their lifetime, with that figure rising to nearly 50% among dogs over 10 years of age. Certain breeds carry disproportionate oncological risk. For instance, as per a March 2026 publication by ImpriMed, 60% of Golden Retrievers are estimated to die of cancer-related causes, with the breed accounting for 9.25% of all diagnosed canine lymphoma and leukemia cases.
The four most prevalent malignancies, namely lymphoma, hemangiosarcoma, osteosarcoma, and mast cell tumors, collectively account for approximately 80% of cancer-related fatalities in this breed alone. Since curative outcomes remain limited across most of these diagnoses, a substantial proportion of affected animals transition into palliative or hospice care frameworks focused on comfort and quality-of-life management rather than disease reversal.
Beyond oncology, the geriatric pet cohort presents with multi-morbidity patterns, including concurrent renal insufficiency, cardiac disease, degenerative joint conditions, and neurological decline, that further fuel demand for structured hospice protocols. Academic institutions have recognized this clinical imperative; NC State's Omega Transitional Care Service and similar programs at veterinary colleges are operationalizing structured hospice pathways precisely in response to rising caseloads of terminally ill companion animals.
This product will be delivered within 1-3 business days.
The global companion animal population is aging, expanding the addressable base for pet hospice services. Improved routine veterinary care, advances in nutrition, and wider access to diagnostics have extended average pet lifespans over the past two decades, producing a structurally larger cohort of geriatric animals requiring sustained end-of-life management. This demographic shift is particularly pronounced among dogs and cats, the two species that account for the dominant share of pet hospice demand, where the incidence of chronic, age-associated terminal conditions has risen in tandem with longer lifespans.
Cancer represents the most clinically significant terminal condition driving hospice referrals. According to a December 2025 publication by PetMD, approximately 25%, i.e., around 1 in 4, of dogs will develop some form of cancer during their lifetime, with that figure rising to nearly 50% among dogs over 10 years of age. Certain breeds carry disproportionate oncological risk. For instance, as per a March 2026 publication by ImpriMed, 60% of Golden Retrievers are estimated to die of cancer-related causes, with the breed accounting for 9.25% of all diagnosed canine lymphoma and leukemia cases.
The four most prevalent malignancies, namely lymphoma, hemangiosarcoma, osteosarcoma, and mast cell tumors, collectively account for approximately 80% of cancer-related fatalities in this breed alone. Since curative outcomes remain limited across most of these diagnoses, a substantial proportion of affected animals transition into palliative or hospice care frameworks focused on comfort and quality-of-life management rather than disease reversal.
Beyond oncology, the geriatric pet cohort presents with multi-morbidity patterns, including concurrent renal insufficiency, cardiac disease, degenerative joint conditions, and neurological decline, that further fuel demand for structured hospice protocols. Academic institutions have recognized this clinical imperative; NC State's Omega Transitional Care Service and similar programs at veterinary colleges are operationalizing structured hospice pathways precisely in response to rising caseloads of terminally ill companion animals.
Global Pet Hospice Services Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global pet hospice services market report based on service, pet, provider, and region:Service Outlook (Revenue, USD Million, 2021-2033)
- At-home Hospice
- At-institution Hospice
Pet Outlook (Revenue, USD Million, 2021-2033)
- Dogs
- Cats
- Other pets
Provider Outlook (Revenue, USD Million, 2021-2033)
- Veterinary Clinical Institutions
- Specialized Providers
Region Outlook (Revenue, USD Million, 2021-2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
- Kuwait
- Qatar
- Oman
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variable Trends & Scope
Chapter 4. Pet Hospice Services Market: by Service Estimates & Trend Analysis
Chapter 5. Pet Hospice Services Market: by Pet Estimates & Trend Analysis
Chapter 6. Pet Hospice Services Market: by Provider Estimates & Trend Analysis
Chapter 7. Pet Hospice Services Market: by Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- VCA Animal Hospitals
- AniCura
- IVC Evidensia
- Creature Comfort Clinic LLC
- HomeVet
- BluePearl Holdings LLC
- Vetessential Healthcare Sdn Bhd.
- Evergreen Veterinary
- CodaPet
- Dignipets Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | April 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 0.7 Billion |
| Forecasted Market Value ( USD | $ 1.5 Billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
